Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
43.56
-1.77 (-3.90%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.09 billion as of April 28, 2026. Its market cap has increased by 238.46% in one year.
Market Cap
3.09B
Enterprise Value
1.65B
1-Year Change
238.46%
Ranking
Category
Stock Price
$43.56
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.09B, an increase of 462.27%. That is a compound annual growth rate of 70.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.09B | -35.83% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.33B |
| NewAmsterdam Pharma Company | 3.30B |
| Denali Therapeutics | 3.18B |
| Arcus Biosciences | 3.12B |
| Erasca | 3.08B |
| Beam Therapeutics | 3.06B |
| Alumis | 3.06B |
| Dyne Therapeutics | 3.00B |